Last update 29 Nov 2024

Anti-Trop2 Universal CAR-NK cell(Henan Cancer Hospital)

Overview

Basic Info

Drug Type
CAR-NK
Synonyms
Anti-Trop2 CAR-NK Cells (Henan Cancer Hospital), Trop2 CAR-NK (Henan Cancer Hospital)
Target
Trop-2
Mechanism
Trop-2 modulators(Tumor-associated calcium signal transducer 2 modulators), Immunologic cytotoxicity, Natural killer cell replacements
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Recurrent Non-Small Cell Lung CancerAdvanced Lung Non-Small Cell Squamous Carcinoma
Inactive Indication-
Originator Organization
Henan Cancer HospitalHenan Cancer Hospital
Active Organization
Henan Cancer HospitalHenan Cancer HospitalHenan Institute of Medical Sciences
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-Trop2 Universal CAR-NK cell(Henan Cancer Hospital)
NCT06454890 / Not yet recruitingPhase 1/2IIT
An Investigator-initiated Trial Evaluating the Efficacy and Safety of Anti-Trop2 Universal CAR-NK(U-CAR-NK) Cells Therapy Combined With Chemotherapy for Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
100 Clinical Results associated with Anti-Trop2 Universal CAR-NK cell(Henan Cancer Hospital)
Login to view more data
100 Translational Medicine associated with Anti-Trop2 Universal CAR-NK cell(Henan Cancer Hospital)
Login to view more data
100 Patents (Medical) associated with Anti-Trop2 Universal CAR-NK cell(Henan Cancer Hospital)
Login to view more data
100 Deals associated with Anti-Trop2 Universal CAR-NK cell(Henan Cancer Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent Non-Small Cell Lung CancerPhase 2-
Henan Cancer HospitalHenan Cancer Hospital
01 Aug 2024
Advanced Lung Non-Small Cell Squamous CarcinomaPhase 1
CN
Henan Cancer HospitalHenan Cancer Hospital
10 Sep 2024
Advanced Lung Non-Small Cell Squamous CarcinomaPhase 1
CN
Henan Institute of Medical Sciences
10 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free